Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) reached a new 52-week low during trading on Thursday . The company traded as low as $10.45 and last traded at $10.55, with a volume of 965014 shares changing hands. The stock had previously closed at $10.77.
Analyst Upgrades and Downgrades
Separately, BNP Paribas upgraded Reckitt Benckiser Group from an "underperform" rating to a "neutral" rating in a report on Tuesday, January 9th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $6,978.00.
View Our Latest Analysis on RBGLY
Reckitt Benckiser Group Stock Up 0.7 %
The firm has a fifty day simple moving average of $12.80 and a 200-day simple moving average of $13.50.
Reckitt Benckiser Group Increases Dividend
The firm also recently announced a dividend, which will be paid on Monday, June 3rd. Investors of record on Friday, April 12th will be paid a dividend of $0.2701 per share. This is a boost from Reckitt Benckiser Group's previous dividend of $0.18. The ex-dividend date is Thursday, April 11th.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.
Further Reading
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
